Center of Excellence: Cardiovascular Risk: News & Perspective

 
 
  • Mediterranean Diet Especially Protective Against Stroke in Women? Greater adherence to the Mediterranean diet was associated with lower risk for stroke in a UK population, with a stronger effect in women than in men.
  • EU Okays CV Benefit Labeling for Canagliflozin in Diabetes The European label for the SGLT2 inhibitor canagliflozin for type 2 diabetes will now include positive cardiovascular benefit results from the CANVAS trial, while a decision from the US FDA is forthcoming.
  • HYP 2018Lifestyle Change Curbs Need for Antihypertensive Agents Lifestyle interventions can reduce the need for antihypertensive medications in men and women with elevated blood pressure, a finding that supports the new hypertension guidelines, researchers say.
  • To Live Longer, Forget the Treadmill and Play Tennis Compared with being sedentary, the gain in life expectancy was almost 10 years with regular tennis playing vs a year and a half with health club workouts, an observational study found.
  • HYP 2018Food Insecurity Linked to High Blood Pressure in Kids Children who lack good access to nutritional foods are at increased risk of having high blood pressure, prompting a call for providers to screen for food insecurity as a heart disease risk factor.
  • Statin Benefits After 75 Limited to Patients With Diabetes Analysis of NHANES data showed no overall benefit of statins for primary prevention, with the exception of adults with type 2 diabetes, and only for those aged 75 to 84 years.
  • Baseline Cardiac Imaging in Breast Cancer Needs to Change Women who receive chemotherapy for early-stage breast cancer are screened at baseline for underlying heart disease according to the treatment they are receiving, rather than their actual risk for heart failure.
  • Omega-3s: Is This the Final Word?   Omega-3s haven't lived up to their hype, and the latest news is no better.
  • ESC 2018Low-Carb Diets Linked to Higher All-Cause Mortality A low-carb diet was associated with earlier death from any cause, heart disease, and cancer in an observational study and meta-analysis, but one expert urges caution when interpreting the finding.
  • Strike Three for Aspirin in Primary Prevention   Three more studies seal the deal: Aspirin no longer has a role to play in primary prevention of heart attacks, says Perry Wilson.
  • ASPREE: No Benefit of Aspirin in Primary Prevention Findings of the ASPREE trial show no benefit, at all, of aspirin in primary prevention of disability-free survival, cardiovascular events and death, or all-cause death in healthy elderly people.
  • PURE: Higher Dairy Consumption Tied to Lower CVD, Mortality Whole-fat dairy is considered detrimental to cardiovascular health, but new data from the large PURE epidemiological study suggests dairy, particularly whole-fat products, may protect against CVD.
  • Adolescents Conceived by ART Show Increased Vascular Aging A follow-up of healthy adolescents conceived through assisted reproductive technologies shows persistent premature vascular aging and progression to hypertension.
  • PURE and Simple Diet Lowers Mortality, CVD Events   The global PURE study identified seven dietary components which, in moderation, may be associated with a reduced risk for premature mortality. Dr Mandrola learns more from investigator Dr Andrew Mente.
  • Top News From ESC 2018: Slideshow Headlines from the world's largest cardiology meeting include surprising negative trials of fish oil supplements and aspirin for cardiovascular prevention.
  • Remembering Dr Ron Victor, Pioneer in Barbershop-Led HTN Efforts Victor was the first investigator to prove scientifically that thousands of lives could be saved annually by enlisting black barbers in the fight against hypertension in their communities.
  • Greater Physical Activity May Reduce HF Risk After Menopause The study is the first to show a benefit with recreational exercise on both subtypes of heart failure. 'The final message? That's an easy one: Sit less and move more,' the study author says.
  • Primary Prevention in Diabetes: Is Aspirin the Answer?   We've heard a lot about aspirin lately, but what do we know about aspirin in patients with diabetes?
  • HYP 2018 Read clinically focused news coverage of key developments from HYP 2018
  • Who Is the 'Cardiometabolic Specialist'?   With new diabetes drugs available that lower cardiovascular risk, the question arises over which specialty will manage this area of medicine. Or will a new specialty emerge?